Role of PU.1 in MHC class II expression through transcriptional regulation of class II transactivator pI in dendritic cells

Journal of Allergy and Clinical Immunology

Volumn 129, Issue 3, 2012, Pages

  Kitamura, Nao ^a   Yokoyama, Hokuto ^a,b   Yashiro, Takuya ^a   Nakano, Nobuhiro ^a   Nishiyama, Makoto ^b   Kanada, Shunsuke ^a   Fukai, Tatsuo ^a   Hara, Mutsuko ^a   Ikeda, Shigaku ^a   Ogawa, Hideoki ^a   Okumura, Ko ^a   Nishiyama, Chiharu ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

class II transactivator; dendritic cells; MHC class II; PU.1

Indexed keywords

HISTONE H3; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; INTERFERON REGULATORY FACTOR 4; LIPOPOLYSACCHARIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MESSENGER RNA; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR PU 1;

ACETYLATION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CHROMATIN IMMUNOPRECIPITATION; DENDRITIC CELL; ELECTROPHORETIC MOBILITY; HISTONE ACETYLATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION;

EID: 84857796069     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.10.019     Document Type: Article

References (37)

1. W. Reith, S. LeibundGut-Landmann, and J.M. Waldburger Regulation of MHC class II gene expression by the class II transactivator Nat Rev Immunol 5 2005 793 806 (Pubitemid 41400853)
2. A. Muhlethaler-Mottet, L.A. Otten, V. Steimle, and B. Mach Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA EMBO J 16 1997 2851 2860 (Pubitemid 27226221)
3. A. Muhlethaler-Mottet, W. Di Berardino, L.A. Otten, and B. Mach Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1 Immunity 8 1998 157 166 (Pubitemid 28123743)
4. R.K. Pai, D. Askew, W.H. Boom, and C.V. Harding Regulation of class II MHC expression in APCs: roles of types I, III, and IV class II transactivator J Immunol 169 2002 1326 1333 (Pubitemid 34809175)
5. T.M. Holling, N. van der Stoep, E. Quinten, and P.J. van den Elsen Activated human T cells accomplish MHC class II expression through T cell-specific occupation of class II transactivator promoter III J Immunol 168 2002 763 770 (Pubitemid 34049577)
6. S. LeibundGut-Landmann, J.M. Waldburger, C. Reis e Sousa, H. Acha-Orbea, and W. Reith MHC class II expression is differentially regulated in plasmacytoid and conventional dendritic cells Nat Immunol 5 2004 899 908 (Pubitemid 39276234)
7. S.R. McKercher, B.E. Torbett, K.L. Anderson, G.W. Henkel, D.J. Vestal, and H. Baribault Targeted disruption of the PU.1 gene results in multiple hematopoietic abnormalities EMBO J 15 1996 5647 5658 (Pubitemid 26385624)
8. E.W. Scott, M.C. Simon, J. Anastasi, and H. Singh Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages Science 265 1994 1573 1577
9. E.W. Scott, R.C. Fisher, M.C. Olson, E.W. Kehrli, M.C. Simon, and H. Singh PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors Immunity 6 1997 437 447 (Pubitemid 27208199)
10. K.L. Anderson, H. Perkin, C.D. Surh, S. Venturini, R.A. Maki, and B.E. Torbett Transcription factor PU.1 is necessary for development of thymic and myeloid progenitor-derived dendritic cells J Immunol 164 2000 1855 1861 (Pubitemid 30108739)
11. A. Guerriero, P.B. Langmuir, L.M. Spain, and E.W. Scott PU.1 is required for myeloid-derived but not lymphoid-derived dendritic cells Blood 95 2000 879 885 (Pubitemid 30062709)
12. C. Nishiyama, M. Nishiyama, T. Ito, S. Masaki, K. Maeda, and N. Masuoka Overproduction of PU.1 in mast cell progenitors: its effect on monocyte- and mast cell-specific gene expression Biochem Biophys Res Commun 313 2004 516 521 (Pubitemid 38021858)
13. T. Ito, C. Nishiyama, M. Nishiyama, H. Matsuda, K. Maeda, and Y. Akizawa Mast cells acquire monocyte-specific gene expression and monocyte-like morphology by overproduction of PU.1 J Immunol 174 2005 376 383 (Pubitemid 40007425)
14. S. Kanada, C. Nishiyama, N. Nakano, R. Suzuki, K. Maeda, and M. Hara Critical role of transcription factor PU.1 in the expression of CD80 and CD86 on dendritic cells Blood 117 2011 2211 2222
15. M.B. Lutz, N. Kukutsch, A.L. Ogilvie, S. Rossner, F. Koch, and N. Romani An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow J Immunol Methods 223 1999 77 92 (Pubitemid 29096240)
16. K. Maeda, C. Nishiyama, T. Tokura, H. Nakano, S. Kanada, and M. Nishiyama FOG-1 represses GATA-1-dependent FcepsilonRI beta-chain transcription: transcriptional mechanism of mast-cell-specific gene expression in mice Blood 108 2006 262 269 (Pubitemid 43990637)
17. N. Nakano, C. Nishiyama, S. Kanada, Y. Niwa, N. Shimokawa, and H. Ushio Involvement of mast cells in IL-12/23 p40 production is essential for survival from polymicrobial infections Blood 109 2007 4846 4855 (Pubitemid 46827781)
18. N. Nakano, C. Nishiyama, H. Yagita, A. Koyanagi, H. Akiba, and S. Chiba Notch signaling confers antigen-presenting cell functions on mast cells J Allergy Clin Immunol 123 2009 74 81 e1
19. S. Kanada, N. Nakano, D.P. Potaczek, K. Maeda, N. Shimokawa, and Y. Niwa Two different transcription factors discriminate the -315C>T polymorphism of the FcepsilonRIalpha gene: binding of Sp1 to -315C and of a high mobility group-related molecule to -315T J Immunol 180 2008 8204 8210
20. C. Nishiyama, M. Hasegawa, M. Nishiyama, K. Takahashi, Y. Akizawa, and T. Yokota Regulation of human Fc epsilon RI alpha-chain gene expression by multiple transcription factors J Immunol 168 2002 4546 4552 (Pubitemid 34441359)
21. C. Nishiyama, Y. Akizawa, M. Nishiyama, T. Tokura, H. Kawada, and K. Mitsuishi Polymorphisms in the FcepsilonRIbeta promoter region affecting transcription activity: a possible promoter-dependent mechanism for association between FcepsilonRIbeta and atopy J Immunol 173 2004 6458 6464 (Pubitemid 39487807)
22. N. van der Stoep, E. Quinten, M. Marcondes Rezende, and P.J. van den Elsen E47, IRF-4, and PU.1 synergize to induce B-cell-specific activation of the class II transactivator promoter III (CIITA-PIII) Blood 104 2004 2849 2857 (Pubitemid 39434971)
23. H. Yoon, and J.M. Boss PU.1 binds to a distal regulatory element that is necessary for B cell-specific expression of CIITA J Immunol 184 2010 5018 5028
24. S. Landmann, A. Muhlethaler-Mottet, L. Bernasconi, T. Suter, J.M. Waldburger, and K. Masternak Maturation of dendritic cells is accompanied by rapid transcriptional silencing of class II transactivator (CIITA) expression J Exp Med 194 2001 379 391 (Pubitemid 32835035)
25. C.R. Escalante, A.L. Brass, J.M. Pongubala, E. Shatova, L. Shen, and H. Singh Crystal structure of PU.1/IRF-4/DNA ternary complex Mol Cell 10 2002 1097 1105 (Pubitemid 35453827)
26. H.C. Chang, S. Sehra, R. Goswami, W. Yao, Q. Yu, and G.L. Stritesky The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation Nat Immunol 11 2010 527 534
27. A. Dakic, L. Wu, and S.L. Nutt Is PU.1 a dosage-sensitive regulator of haemopoietic lineage commitment and leukaemogenesis? Trends Immunol 28 2007 108 114 (Pubitemid 46283693)
28. S. Carotta, A. Dakic, A. D'Amico, S.H. Pang, K.T. Greig, and S.L. Nutt The transcription factor PU.1 controls dendritic cell development and Flt3 cytokine receptor expression in a dose-dependent manner Immunity 32 2010 628 641
29. M.R. Green, H. Yoon, and J.M. Boss Epigenetic regulation during B cell differentiation controls CIITA promoter accessibility J Immunol 177 2006 3865 3873 (Pubitemid 44359921)
30. T. Ito, C. Nishiyama, N. Nakano, M. Nishiyama, Y. Usui, and K. Takeda Roles of PU.1 in monocyte- and mast cell-specific gene regulation: PU.1 transactivates CIITA pIV in cooperation with IFN-gamma Int Immunol 21 2009 803 816
31. M. Hamdorf, A. Berger, S. Schule, J. Reinhardt, and E. Flory PKCδ-induced PU.1 phosphorylation promotes hematopoietic stem cell differentiation to dendritic cells Stem Cells 29 2011 297 306
32. E. Walseng, K. Furuta, R.S. Goldszmid, K.A. Weih, A. Sher, and P.A. Roche Dendritic cell activation prevents MHC class II ubiquitination and promotes MHC class II survival regardless of the activation stimulus J Biol Chem 285 2010 41749 41754
33. M.A. Smith, G. Wright, J. Wu, P. Tailor, K. Ozato, and X. Chen Positive regulatory domain 1 (PRDM1) and IRF8/Pu.1 counter regulate MHC Class II transactivator (CIITA) expression during dendritic cell maturation J Biol Chem 286 2011 7893 7904
34. S.L. Nutt, D. Metcalf, A. D'Amico, M. Polli, and L. Wu Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors J Exp Med 201 2005 221 231 (Pubitemid 40189431)
35. T. Ito, C. Nishiyama, N. Nakano, M. Nishiyama, Y. Usui, and K. Takeda Roles of PU.1 in monocyte- and mast cell-specific gene regulation: PU.1 transactivates CIITA pIV in cooperation with IFN-gamma Int Immunol 21 2009 803 816
36. C. Nishiyama, T. Yokota, K. Okumura, and C. Ra The transcription factors Elf-1 and GATA-1 bind to cell-specific enhancer elements of human high-affinity IgE receptor alpha-chain gene J Immunol 163 1999 623 630 (Pubitemid 29328065)
37. K. Maeda, C. Nishiyama, T. Tokura, Y. Akizawa, and M. Nishiyama Regulation of cell type-specific mouse Fc epsilon RI beta-chain gene expression by GATA-1 via four GATA motifs in the promoter J Immunol 170 2003 334 340 (Pubitemid 36026157)